Compare DexCom, Inc. (DXCM) vs Vistra Corp (VST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Vistra Corp — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Vistra Corp trades at $146.52 (market cap $48.64B). The key difference: Vistra Corp is the larger of the two by market cap, and Vistra Corp pays a 0.63% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | VST | |
|---|---|---|
Market Cap | $33.79B | $48.64B |
Sector | Health | Technology |
52-Week High | $89.53 | $217.92 |
52-Week Low | $54.84 | $134.71 |
Enterprise Value | $33.24B | $70.58B |
Dividend Yield | — | 0.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →
